Research and Development

The Research and Development (R&D) team at SpectronRx focuses on innovating and optimizing processes for the development and handling of therapeutic and diagnostic isotopes, such as Pb-212, Lu-177, Ac-225, and I-131. This team is responsible for advancing the company's capabilities in pharmaceutical grade isotope labeling and contract manufacturing, ensuring adherence to stringent FDA and EMA standards. Their work involves extensive experimentation, refining production methods, and collaborating closely with other departments to bring new radiopharmaceutical solutions from concept to clinical application.